INTRODUCTION
Studies of individuals exposed to moderate doses of radiation, generally at high dose rates, such as survivors of the atomic bombings in Japan have demonstrated that leukemia is one of the cancers most susceptible to induction by ionizing radiation and that it can occur very soon after radiation exposure (1) (2) (3) . However, there remains considerable interest in the relationship between protracted exposure to low doses of radiation and leukemia, because these types of exposure are most likely to be encountered by the general public and radiation workers (1) .
The accident at the Chornobyl (Chernobyl) nuclear power plant in northern Ukraine in April 1986, as well as being a public health, social and economic disaster for the countries most affected, also provided an opportunity to evaluate the relationship between leukemia and low-dose and lowdose-rate radiation (4) . After the accident, several hundred thousand workers who were involved in cleaning up the site and its surroundings received fractionated whole-body doses, primarily from external radiation (1) . To date, only studies of workers from the Russian Federation have attempted to quantify the risk of leukemia among Chornobyl cleanup workers (5) (6) (7) (8) . Data from these studies suggest an association between leukemia and radiation exposure, but the magnitude of the radiation effect is unclear due to substantial uncertainty in dose estimates (1) . Buzunov et al. reported an increased risk of leukemia among Ukrainian cleanup workers, but dose estimates were not available and evaluation was based only on the year first worked at the accident site (9) .
To increase our understanding of the role of protracted a These cases were identified as large granular lymphocytic leukemia and were verified by immunophenotypic surface markers as two cases of the T-cell type and two cases of the NK-cell type.
b Chronic lymphocytic leukemia.
low-dose radiation exposure in the etiology of leukemia, we conducted a nested case-control study of leukemia in Ukrainian cleanup workers.
MATERIALS AND METHODS
We provided a full description of the study in the first paper in this series (10) that we briefly summarize below.
Cases
We identified a cohort of 110,645 workers from the Chornobyl State Registry of Ukraine (SRU) who participated in Chornobyl cleanup activities before 1991 and who were initially registered in one of five oblasts 3 (Chernihiv, Cherkasy, Kharkiv, Kyiv and Dnipropetrovsk) or Kyiv City. The selected geographical area allowed for easy access by study investigators and included a large number of cleanup workers. The cohort represents 46% of all cleanup workers included in the SRU.
We ascertained potential cases of leukemia occurring within the cohort between 1986 and 2000 through computerized linkage (11) of cohort records and a Provisional Leukemia Registry (10) . We established an expert international panel of five hematologists and hematopathologists to review all diagnoses (12) . The Panel was given 128 potential leukemia cases to review [111 with a preliminary diagnosis of leukemia and 17 with a preliminary diagnosis of myelodysplastic syndrome (MDS)], and they confirmed 87 cases of leukemia (Table 1 ) and six cases of MDS. The Panel initially classified the leukemia cases using the French-American-British (FAB) system but changed to the WHO system of classification in 2007 (13) . Complete medical records, including a description of the histological confirmation of the diagnosis, were available for all cases. In 56 (64.4%) of 87 confirmed cases, diagnosis was supported by biological material. Sixteen cases were excluded from risk analysis because their doses could not be calculated reliably (two proved to be ineligible, seven could not be traced, four refused to complete the dosimetry questionnaire, and for three the quality of interview was inadequate). Thus our analysis included 71 cases of the 87 (81.6%) confirmed cases of leukemia, and, as shown in Table 1 , this participation rate was similar for all leukemia cases excluding chronic lymphocytic leukemia (CLL) and CLL cases separately (P ϭ 0.58). Participating cases ranged in age at diagnosis from 25 to 69 years (median ϭ 49). Separate analyses of 3 Oblast is an administrative unit similar in size to a state or province.
the MDS dose response could not be performed due to the small number of cases.
Due to the high mortality rate of leukemia patients and since we conducted interviews between 2002 and 2004 for cases diagnosed in 1986-2000, we had to interview proxy respondents for 60% of case subjects, mainly next-of-kin for personal, residential and medical history and coworkers for Chornobyl work history. In contrast, since most control subjects were alive, we relied on proxy interviews for only 7.2%.
Controls
For each potential leukemia case, to achieve a 5:1 matching ratio, we randomly selected five to nine control subjects from members of the cohort who were alive and at risk at the time of the case's diagnosis (incidence density sampling) and matched on oblast or Kyiv City and year of birth. Of the selected 792 controls, 536 were interviewed, 101 refused to participate, 133 could not be traced, and 22 moved out of the study regions (response rate of 71.6% for alive controls, 60.2% for nextof-kin, and 66.1% for colleagues responding for deceased controls). Of the interviewed controls, 348 were originally selected for 71 confirmed leukemia cases and the remaining 188 controls had been selected and interviewed for cases that were not included in the study because their initial diagnosis was not confirmed by the study hematologist, their final diagnosis was not confirmed by the international panel, or they did not participate in this study. We attempted to match the latter group of controls to the 71 confirmed cases, but only 153 (81.3%) could be matched; thus the total number of controls used in this analysis is 501. Analyses with and without these additional 153 controls showed essentially similar results, but the additional controls improved the precision of analyses. Match on year of birth was achieved for 442 controls (88.2%). The remaining controls were matched within 2 years of birth (n ϭ 35 or 7.0%) or within 5 years of birth (n ϭ 24 or 4.8%).
Dosimetry
The RADRUE dosimetry method was used to estimate individual Chornobyl-related bone marrow doses for all cases and controls (14) . The method uses detailed interviews with study subjects or, if they were deceased, with their next-of-kin for demographic and medical data and coworker proxies for the details of cleanup activities, carried out by trained interviewers to ascertain Chornobyl work and residential history. The interview included questions on workers' activities during cleanup, location of places of work and residence, types of work, transportation routes to and from work, and corresponding dates. An expert dosimetrist used the questionnaire data in combination with a database of field exposure measurements to estimate the total Chornobyl-related dose for each subject (including both cleanup activities and residence in the highly contaminated areas). Investigators have tested and validated the RADRUE dose estimation methodology (14) .
The RADRUE method was used to calculate 10,000 annual bone marrow dose estimates for 1986-1990 (all cleanup work ceased in 1990) for each study subject by generating 10,000 realizations of a dose prediction equation by random sampling from assumed distributions of model parameters.
Statistical Analysis
We used standard conditional logistic regression for matched sets for all analyses. We computed odds ratios (OR) to estimate relative risks (RR) in four dose categories (0-1.9, 2.0-19.9, 20.0-149.9, 150.0-3220 mGy) based on the categorization of the case dose distribution approximately into quarters. We fit an excess relative risk (ERR) model for continuous doses, Risk ϭ background risk where ␤ is the ERR per Gy, Z i represents potential modifying factors, and ␥ i represents their corresponding parameters. In this equation, the effect of dose multiplies the background risk, and by adding 1.0 to the ERR, one obtains the relative risk at 1 Gy. Model 1 is a linear model in dose, although we evaluated several alternative forms, including linearquadratic, power and exponential models. For these analyses, we used the PECAN module from the EPICURE suite of programs (15) to derive point and confidence interval (CI) estimates for all parameters based on maximum likelihood estimation procedures and used likelihood ratio tests for tests of hypotheses. All P values are two-sided. We conducted analyses for all leukemias and separately for CLL and non-CLL. We investigated calendar period first worked in the 30-km Chornobyl zone (categorized into April-May 1986, June-December 1986, 1987 and 1988-1990), duration of mission, i.e., total time worked within the zone (up to 1, 2-3, 4-5 and 6ϩ months), number of missions (1, 2, 3 and 4ϩ), type of work performed in the zone during the first mission (grouped into early responders, military personnel, professional nuclear power workers and other), as well as smoking (never-, ex-and current smokers of 1-9, 10-19, and Ն20 cigarettes/day), alcohol consumption (never, once a month or less, two or three times a month, once a week, several times a week, every day), education (8 years or less, high school, trade school, higher education), attained age, and urban/rural residence as potential independent risk factors of leukemia after adjustment for radiation exposure. We also investigated possible effects of occupational exposures to chemicals and radiation due to employment in hazardous industries before or after the cleanup work at Chornobyl (yes, no). We retained adjustment variables in the model if they significantly improved the model fit or changed the risk estimate by more than 10%. The percentage of missing information for these variables was very low and did not exceed 4%.
We also evaluated age at first exposure, number of missions within the Chornobyl zone, year of first mission, type of work performed, total duration in the zone, and source of information (subject or proxy respondent) as possible effect modifiers of the dose effect.
The analyses in this report were based on the cumulative doses derived as the sums of the arithmetic means of the annual dose estimates. We assessed lag interval, a period of recent exposure assumed unrelated to disease, for the calculation of cumulative dose from 1986 to 1990 in 1-year increments between 0 and 10 years. The deviance, a measure of model fit, was minimized for both CLL and non-CLL analyses when we set the lag interval to 2 years. We therefore used a lag of 2 years for the calculation of cumulative dose in all analyses. Cumulative doses ranged from 0 to 3220 mGy for cases and from 0 to 2600 mGy for controls (mean ϭ 76.4, SD ϭ 213.4 mGy, 2-year lag). We also conducted several additional exploratory analyses using unlagged annual doses. Table 2 shows selected descriptive characteristics of study subjects. Case and control subjects did not differ by year of birth, geographic area, type (urban/rural) of residence, or educational level. Among the 71 cases used in the analysis, the International Hematology Panel classified 39 cases as CLL (55%) and 32 as non-CLL (45%).
RESULTS
After adjustment for dose, the odds ratio (OR) by calendar period first worked April/May 1986 was 1.64 relative to first worked between 1988 and 1990, but this difference was not statistically significant (Table 3) . ORs for duration of cleanup work at Chornobyl were close to unity, and there was no clear trend. Similarly, number of missions and type of work performed in the 30-km zone showed no variation in risk after adjustment for dose. As shown in Table 4 , the OR for total leukemia increased with dose categories (P ϭ 0.03 for test of linear trend). Although based on few cases, we further divided the highest dose category ( Fig. 1 ) (150.0-3220.0 mGy) into two and found a somewhat higher risk in the upper dose category (OR ϭ 2.21; 95% CI: 0.87-5.57 and OR ϭ 2.89; 95% CI: 1.12-7.46 for categories of 150.0-274.9 and 275.0-3220.0 mGy, respectively). Analyses were also done separately for CLL and non-CLL. Despite the small number of cases, we observed consistent trends for the two subtypes (P ϭ 0.04 and 0.25 for test of linear trend, respectively), although the P value for the non-CLL cases did not reach statistical significance.
With continuous dose, we estimated an ERR of 3.44 per Gy for all leukemias combined (95% CI: 0.47-9.78, P Ͻ 0.01) ( Table 5 ). The dose-response parameters for CLL (ERR ϭ 4.09 per Gy; 95% CI: Ͻ 0-14.41, P ϭ 0.079) and non-CLL (ERR ϭ 2.73 per Gy; 95% CI: Ͻ 0-13.50, P ϭ 0.052) were consistent. A formal test of homogeneity between the two slopes yielded a P value of 0.75, indicating no significant difference in the effects for non-CLL and CLL cases.
We found no evidence that the dose-response estimates for total leukemia or leukemia subtypes were confounded by smoking, alcohol, education, attained age, urban/rural residence, occupation or exposure to chemicals (results not shown). Relatively few subjects worked in hazardous industries, and there was no evidence of a measurable association with employment in such industries and risk of leukemia.
When we excluded subjects with doses above 500 mGy to assess the influence of subjects with extremely high doses, we found a comparable estimate of effect (no. of cases ϭ 67, ERR ϭ 3.54 per Gy, 95% CI: Ͻ 0-11.1, P ϭ 0.08). The inclusion of quadratic, exponential or power terms in dose did not improve model fit (P values of 0.77, 0.73, and 0.33, respectively), indicating no evidence of curvilinearity in the dose response.
To assess the validity of a 2-year lag period, we analyzed the 52 cases diagnosed since 1993 separately (2 years after all cleanup work ceased in 1990). The results were very similar to those for all study subjects, i.e., a statistically significant ERR of more than three per Gy (P ϭ 0.02). Comparative analyses of annual doses and cumulative doses lagged by 2 years provided evidence that risk arose primarily from doses received in 1986 (not shown). Table 5 shows the risk estimates for directly interviewed cases and for deceased cases for whom proxy interviews were necessary. Since there were very few proxy-inter- viewed controls, we included all controls in these analyses. The ERR per Gy for directly interviewed cases was 2.5-fold that for proxy cases, although a test of interaction for source of interview data yielded a P value of 0.47. We did not observe a statistically significant interaction for categories of year of diagnosis, duration of missions, or number of missions. However, the ERR was nonsignificantly lower for workers with longer durations of exposure and greater numbers of missions, suggesting a reduced effect with lower dose rate. The ERR for workers first exposed before age 45 years (median age at exposure) was smaller than for those exposed at later ages (P ϭ 0.07 for the likelihood ratio test for interaction effects), and a higher ERR at older ages at exposure was also seen for CLL and non-CLL cases when we analyzed them separately (not shown).
DISCUSSION
In a nested case-control study of Chornobyl cleanup workers in Ukraine, we observed a significant association between Chornobyl-related radiation dose and increased risk of total leukemia. Our risk estimate for Chornobyl cleanup workers exposed to protracted radiation was comparable to that from the Life Span Study of atomic bomb survivors exposed to high-dose-rate ionizing radiation (3). However, while differences were not statistically significant (P Ͼ 0.5), the estimates of ERR for workers exposed for longer durations or from multiple missions were about half those for workers who received their exposure within 1 month or during one mission.
The strengths of this study are many and include the relatively large number of cases and controls compared to other studies of cleanup workers, selection of cases and controls from within a large cohort of cleanup workers from Ukraine, the wide and rigorous search for diagnoses of leukemia and 99 ancillary diagnoses (diagnoses that could be misclassified and therefore mask leukemia) in all medical institutions treating leukemia in the target geographic areas, and confirmation of diagnoses for all study cases by the International Hematology Panel consisting of hematologists and hematopathologists that reviewed medical records for all cases and biological material for a majority of cases.
Furthermore, individual bone marrow doses were estimated for all study subjects by the RADRUE dosimetric method, which allows for the possibility of dose reconstruction for deceased cases and was validated in other studies (14) . The RADRUE doses have been shown to be superior to the ''official'' doses that were found to be available for about a third of cohort members and that are subject to substantial uncertainties. Cumulative individual bone marrow radiation doses were higher than in most studies of Another strength of the study is the high interview participation rates for both cases and controls as well as for alive subjects and proxies used for deceased study subjects. To minimize potential biases, interviewers were not aware of subjects' case-control status and were carefully trained not to ask probing questions beyond those listed on the questionnaire. Similarly, doses were estimated without knowledge of subjects' case-control status and members of the International Hematology Panel did not know the radiation dose of cases under review. Finally, the information collected during interviews allowed the investigation of the effects of a number of potential confounders not generally available in other studies of cleanup workers.
A limitation of the study was that the number of cases who died and thus for whom proxy interviews were necessary was sizable. While the quality of data from the proxy interviews was more uncertain than the data collected directly from subjects, it was deemed sufficient for dose estimation based on the results of re-interviews and interviews of several coworkers for deceased cases (14) . Uncertainties in the RADRUE dose estimates were complex; they included uncertainties in exposure-rate data and soil contamination measurements, uncertainties in the interpolation of these data in time and space, and imprecision of the data from the questionnaire. We believe that the dose uncertainties in our study were primarily classical errors and expect that they will bias risk estimates toward the null. Further analysis of dose uncertainties and their potential effects on risk estimates is planned.
While there are study limitations, the observed association between radiation and leukemia is unlikely to be due to chance given the consistency of the dose-response relationships observed in both categorical and continuous analyses, for annual and cumulative doses, and in the entire dose range as well as for doses less than 500 mGy, when adjusting for other measures of exposure at Chornobyl and for different leukemia cell subtypes. However, it must be recognized that recall bias, i.e., that cases could either preferentially recall their Chornobyl experience or else exaggerate such experiences leading to an overestimation of their dose, cannot be ruled out. The higher ERR seen for non-proxy compared with proxy cases (6.20 and 2.45 per Gy, respectively) could be an indication of recall bias or, more likely, it could reflect greater error in estimating doses for proxy cases.
We observed an increase in the risk of leukemia for workers exposed after age 45 compared to those less than 45, although the difference was not statistically significant. A similar effect has been observed in some studies of nuclear workers exposed to low-dose protracted radiation (16) .
Most published studies of Chornobyl cleanup workers report an elevated risk of leukemia (1, 4) , with much of the evidence coming from studies of Russian cleanup workers who received average doses of 100-200 mGy (5) (6) (7) (8) . Based on the dose and follow-up information for 168,000 workers from the Russian National Medical and Dosimetric Registry, Ivanov et al. (5) reported an increased risk of all leukemia with an ERR of 4.3 per Gy (n ϭ 48). Risk estimation was based on a comparison of the observed incidence with the national incidence of leukemia for males from the same age groups. Two case-control studies from the same registry showed discrepant results: An initial analysis showed no significant trend with dose for all leukemia, leukemia excluding CLL, or liquidators who worked in the 30-km zone in 1986-1987 (7), but a later analysis estimated significant ERRs ranging from 0.28 to 15.59 per Gy for essentially the same groups (8) . Methodological concerns prompted Boice and Holm to question the validity of this analysis (17) . In a more recent cohort analysis of 42 cases of non-CLL among 71,870 workers from the same registry, Ivanov et al. (6) reported a significantly increased ERR of 6.7 per Gy. The reasons for the differences in estimates are not clear, but the large uncertainties in ''official'' doses from the Chornobyl Registry and absence of rigorous histopathological case verification are a concern.
Buzunov et al. (9) conducted an ecological study of leukemia occurrence among approximately 175,000 liquidators in Ukraine using data from the State Registry of Ukraine and national leukemia morbidity statistics. Leukemia incidence rates for workers first employed in 1986, when doses were relatively high, were double those for workers employed in 1987, when doses were lower.
Our findings also can be compared with those from studies of nuclear workers who were exposed to low doses of radiation at low dose rates (16, 18) . In a pooled analysis of workers from 15 countries, approximately 400,000 nuclear workers were monitored for external radiation. Despite the large number of workers, the confidence interval for the nearly twofold ERR per Gy for leukemia excluding CLL remained wide and included unity (ERR ϭ 1.93 per Gy, 95% CI: Ͻ 0, 8.47) (18) . We found a similar increase in non-CLL leukemia (ERR ϭ 2.73 per Gy, 95% CI Ͻ 0-13.50). A recent analysis of leukemia mortality in the cohort of U.S. shipyard workers exposed to protracted lowlevel ␥ radiation (19) also found a nonsignificant increase in risk with increasing radiation dose. Krestinina et al. recently reported that subjects exposed to protracted internal and external environmental ionizing radiation from radioactive discharges from the Mayak nuclear weapons complex (mean bone marrow dose ϭ 300 mGy) had a significantly increased risk of total leukemia. The number of deaths from CLL was small, and the dose response for CLL alone was not significant (20) .
Among males exposed to acute radiation from the atomic bombs between the ages of 20 and 60 years (similar to the present study), the ERR for non-CLL is about 3 per Gy (based on the linear term of a linear quadratic dose-response relationship) (18) . Data on CLL are not available because CLL is very rare in Japan (2). Because radiation-related leukemia risk has been shown to decrease with time since exposure, it is reasonable to predict that during the first 10-20 years of follow-up after the Chornobyl accident excess risk would be higher (approximately three-to fourfold) (2, 21) . Thus our results for non-CLL appear to be consistent with those from the study of atomic bomb survivors.
A likely cause of the high proportion of CLL cases in our study (55%) compared with only about 40% reported by population-based cancer registries is the difference in the level of medical monitoring and diagnostic tools used (22, 23) . Zent et al. (24) suggested that, due to the rather indolent nature of CLL, tumor registries may be missing as much as 38% of CLL compared with the incidence of CLL detected using sophisticated measures such as flow cytometric immunophenotypic analysis. Because annual medical examinations including blood tests and a visit to a hematologist are mandatory for all cleanup workers registered in the SRU (25, 26) , it would be expected that a large number of cases would be detected that would not have been diagnosed among people receiving routine medical care. Indeed, Gluzman et al. (26) reported that 49% of total leukemia diagnosed among the Ukrainian Chernobyl cleanup workers 10-20 years after the accident were of the CLL subtype compared with only 44% in the age-and sex-comparable general population of Ukraine. The over-representation of CLL cases may also be due to the more benign clinical course and longer survival that led to a greater likelihood of ascertainment (a type of length-bias sampling) using our thorough case-finding protocol. Underascertainment of acute leukemia cases who died prior to being properly diagnosed or whose diagnoses could not be confirmed due to lack of histological materials could also have resulted in over-representation of CLL cases. However, the potential over diagnosis of CLL and under diagnosis of non-CLL cannot account for our observed positive radiation dose-response relationship for CLL since neither situation should be related to dose and because doses were estimated for similar proportions of CLL and non-CLL cases confirmed by the panel (79.6 and 84.2%, respectively, P ϭ 0.58; see Table 1 ).
The generally similar radiation effects we found for CLL and non-CLL is somewhat surprising in view of the lack of significantly increased radiation risks for CLL observed in most other studies (1, 16, 27, 28) . One explanation is that the higher proportion of proxies interviewed for non-CLL cases compared with CLL cases (69 and 51%, respectively, P ϭ 0.14) could have resulted in less precise dose estimates for the non-CLL cases and therefore a reduction in the dose response.
Another explanation may be related to the fact that most other studies are based on mortality data. Analyzing data from atomic bomb survivors, Ron et al. showed that incidence data had greater diagnostic accuracy than mortality data and provided more complete information on relatively nonfatal cancers (29) . Finch and Linet have suggested that over a quarter of all cases of CLL may be asymptomatic for many years, and even after diagnosis survival is significantly longer compared to other types of leukemia (30) . Thus mortality data would underestimate, possibly substantially, the occurrence of CLL. Not surprisingly, recent mortality studies that evaluated dose response for CLL separately had either negative findings (16, 31) or positive findings with a negative dose-response trend (19, 28, 32) . Two recent incidence-based studies of radiation workers have shown an association between CLL and occupational radiation exposure (33, 34) , with one study (33) reporting a significant increase in CLL among Czech uranium miners presumably due to a ␥-radiation component of exposure in the mines and the other study (34) reporting an elevated risk among radiologic technologists who worked during the early years, when occupational doses were presumably high. In contrast, high-dose studies of populations treated with radiotherapy for a first primary cancer showed no increase in the incidence of CLL, whereas a significant increase was demonstrated for all other types of leukemia (35, 36) . Due to the very low CLL incidence in Japan (2), data on the relationship with radiation are not available from studies of atomic bomb survivors.
Some earlier genetic and molecular studies have shown that lymphatic malignancies differ from other types of leukemia, possibly explaining the apparent variation in response to radiation in the two types of leukemia (37, 38) . However, in a recent review of the latest molecular, clinical and epidemiological evidence for radiation-associated risks of CLL, Richardson et al. (39) argue that the somatic mutations involved in CLL etiology are similar to those of other lymphatic neoplasms and that the assumption that CLL is an exception to the principles of radiation carcinogenesis is without firm foundation.
Several studies have demonstrated marked differences in the clinical course and morphological features of CLL diagnosed in Chornobyl cleanup workers and the general population (25, 40, 41) . Chornobyl-associated CLL cases were characterized by younger age, more advanced stage of disease at presentation, and faster progression. Cleanup workers with large radiation doses had CLL characterized by high mutation rates in several genes associated with poor disease prognosis (25, 40) . In our study, CLL cases were characterized by longer survival compared to other subtypes of leukemia (51% and 69% deceased at the time of interview, respectively).
In summary, we found a significant linear dose-response relationship between Chornobyl-related radiation exposure among Ukrainian cleanup workers and risk of total leukemia. Similar to other studies, we found an increased risk for non-CLL. Our finding of an association between CLL and ionizing radiation adds new information to the controversy regarding the effects of radiation on CLL (41) (42) (43) . To further clarify these issues, we are extending the casecontrol study to ascertain cases for another 6 years (2001-2006) .
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